Ashwagandha And Memory — What The Clinical Trials Show
Quick Read Ashwagandha, an herb used in traditional medicine for over 3,000 years, shows measurable effects on memory and thinking
Subscribe to the distribution list, to get regular updates on supplement research for health,
🧠 NeuroBright Our evidence-based brain supplement formulated from 1.7M research papers
Your brain concentrates vitamin C more than any other organ because it needs protection from damage caused by its own high energy use. This damage, called oxidative stress, increases with age and is linked to brain decline. Research shows that people with higher vitamin C intake and blood levels tend to perform better on memory and thinking tests, especially smokers whose bodies burn through vitamin C faster.
However, there’s a catch: simply taking vitamin C supplements doesn’t automatically get it into your brain cells. A special transport system called SVCT2 has to actively pump it across from the bloodstream. In Alzheimer’s disease, this transport system breaks down, which explains why vitamin C supplementation has failed in clinical trials despite the biological logic suggesting it should work. Beyond brain aging, vitamin C may also support mood and stress resilience through its role in neurotransmitter function.
Most human studies showing cognitive benefits are observational, meaning we cannot yet prove vitamin C causes better thinking, only that people who get more of it tend to think better. Animal research strongly supports the mechanisms involved, but large-scale human trials are still needed to confirm how and when supplementation helps.
Verdict: Daily vitamin C supplementation appears safe and sensible as part of brain health strategy, though it is not a standalone solution and should be combined with other protective factors.
Most of us think of vitamin C as the thing we reach for when we feel a sniffle coming on. A glass of orange juice, a fizzy tablet, maybe a gummy or two. Job done. But what if that framing has been quietly underselling one of the most biologically active molecules in your brain? What if the real story of vitamin C isn’t about your immune system at all, it’s about your neurons, your microglia, your memory, and what happens to your brain over the next twenty or thirty years?
Here’s the thing that caught our eye when we reviewed the research: your brain actively hoards vitamin C. Of all the organs in your body, the brain maintains the highest concentration of it. That’s not an accident. The brain is a metabolically furious place, burning oxygen at a rate that generates enormous oxidative stress, and vitamin C is one of its primary defences. Vitacuity analysed over 1.77 million research papers and selected the most relevant studies on this topic. What follows is what we found, and what we honestly don’t know yet.
To understand why vitamin C matters so much to brain health, you need to understand two things: oxidative stress, and the remarkable machinery the brain uses to manage it.
Every time your neurons fire, which is constantly, they produce unstable molecules called free radicals as a by-product. These molecules are electrically charged and will damage whatever they collide with: cell membranes, DNA, proteins. This process is called oxidative stress, and it accelerates with age. Left unchecked, it’s one of the core drivers of neurodegeneration, the gradual deterioration of brain cells and connections that underlies conditions like Alzheimer’s disease [2, 3].
Vitamin C (also called ascorbic acid or ascorbate) is a powerful antioxidant, meaning it neutralises these free radicals before they cause damage. But it does far more than that. Research shows vitamin C plays active roles in neurotransmitter production, synaptic plasticity (the brain’s ability to strengthen connections, the physical basis of learning and memory), epigenetic modulation, and the regulation of neuroinflammation [10]. It’s not a passive bystander: it’s a participant in the ongoing biochemistry of a healthy brain.
There’s a catch, though, and it’s an important one. Unlike most animals, humans cannot manufacture their own vitamin C. We depend entirely on diet and supplementation to maintain our levels [12]. And here’s where things get interesting: even when we consume adequate vitamin C, getting it into the brain requires a dedicated transport protein called SVCT2 (Sodium-Dependent Vitamin C Transporter 2). SVCT2 acts as a gatekeeper, actively pumping ascorbate from the bloodstream into brain cells, neurons and microglia alike [10, 13]. When this system works well, the brain is bathed in vitamin C. When it falters, the brain becomes vulnerable, even if you’re eating well.
Evidence grade: Promising, consistent animal and human observational data, but large-scale human trials are still limited.
The brain’s appetite for vitamin C isn’t subtle. Studies confirm it maintains the highest vitamin C concentration of any organ in the body, and there’s a clear reason: its oxygen consumption is enormous, making oxidative protection essential [12]. The problem is that as we age, this system begins to struggle.
A 2020 mini-review in *Frontiers in Integrative Neuroscience* examined the relationship between plasma and brain vitamin C levels across age groups and genders. The review found that ageing is systematically associated with reductions in plasma vitamin C concentrations, and that older adults appear more vulnerable to declines in the brain’s ability to regulate and utilise vitamin C [6]. In other words, as you get older, you not only tend to have less vitamin C circulating in your blood, your brain also becomes less efficient at using what little it has.
The same review noted that animal studies have shown age-related changes in vitamin C brain distribution, and that these changes may plausibly contribute to age-associated cognitive decline. The authors are appropriately cautious, they call for larger-scale human investigations, but the biological logic is consistent and hard to dismiss [6].
A 2021 transgenic mouse study adds another dimension. Using a mouse model specifically engineered to be unable to synthesise its own vitamin C (much like humans), researchers found that long-term high vitamin C intake was important for maintaining brain cholesterol homeostasis and preventing oxidative damage as the animals aged. Critically, they found that the formation of lipoprotein(a) deposits in the brain, a known vascular risk factor, was negatively correlated with brain vitamin C levels. The higher the brain’s vitamin C, the fewer these damaging deposits [12]. The study was conducted in mice, so human translation requires caution, but the mechanism is consistent with what we understand about vitamin C’s antioxidant role in the ageing brain.
Evidence grade: Promising, large cross-sectional observational data in humans, but causation is not yet established.
A 2025 cross-sectional study published in *Frontiers in Nutrition* examined data from 2,801 US adults aged 60 and over, drawn from the National Health and Nutrition Examination Survey (NHANES) from 2011–2014 [4]. This is one of the larger real-world datasets examining this question, and the findings are striking.
Using three validated cognitive tests, the CERAD Word Learning Test, the Animal Fluency Test (AFT), and the Digit Symbol Substitution Test (DSST), the researchers found a nonlinear dose-response relationship between vitamin C intake and cognitive performance. Participants in the highest intake quartile showed significantly better performance on the Animal Fluency Test and the Digit Symbol Substitution Test compared to those in the lowest quartile [4].
The “nonlinear” finding is particularly interesting: it suggests there’s a threshold effect, cognitive benefits appear to plateau beyond a certain intake level, rather than increasing indefinitely. This is biologically sensible and consistent with how saturation of transport systems works.
There was also a notable subgroup finding: smoking status significantly modified the relationship. Smokers appeared to benefit more from higher vitamin C intake in terms of cognitive protection, which makes biological sense, since smoking dramatically increases oxidative stress and depletes plasma vitamin C [4]. This is one of the more practically useful findings in this dataset: if you smoke, your brain’s need for vitamin C is likely considerably higher than a non-smoker’s.
An important caveat: this is observational, cross-sectional data. It tells us that people with higher vitamin C intake tend to have better cognitive scores at a single point in time. It cannot tell us that vitamin C caused the difference, people who eat more vitamin C-rich foods may differ in dozens of other health behaviours.
Evidence grade: Promising, small pilot human studies, consistent direction but needs replication at scale.
Two studies from 2019 and 2020 explored the relationship between measured plasma vitamin C levels (rather than dietary estimates) and cognitive performance in healthy adults [7, 11].
The 2019 cross-sectional study in *Frontiers in Aging Neuroscience* tested healthy adults, measuring actual blood plasma vitamin C concentrations and using sensitive cognitive assessments designed for age-related vulnerability. Higher plasma vitamin C concentrations were linked with higher cognitive performance [11]. The study used plasma measurement rather than food frequency questionnaires, a more reliable method, though sample sizes were modest.
The 2020 pilot study in *Current Developments in Nutrition* found something additionally interesting: after adjusting for age, medications, and supplementation dose, there was a significant interaction between gender and plasma vitamin C on cognitive performance [7]. Women appeared to show a different cognitive relationship to vitamin C status than men, a finding the authors connect to the established observation that women tend to have higher plasma vitamin C concentrations overall, particularly before the menopause [6]. The authors are appropriately cautious, calling for larger-scale studies to establish cause and effect.
What’s consistent across these studies: adequate plasma vitamin C status, not just dietary intake estimates, but actual measured blood levels, appears to be associated with better performance across several cognitive domains, including attention and recall.
Evidence grade: Early stage, compelling animal and cell research, human therapeutic applications still under development.
This is where the science gets genuinely fascinating, and where it gets more complex.
A 2024 review in a neurobiology journal provided a comprehensive analysis of how ascorbate and its transporter SVCT2 function together in the brain [10]. The review establishes that SVCT2 is the critical mechanism by which vitamin C enters neurons and microglia, the brain’s immune cells. Ascorbate’s role in the brain turns out to be considerably broader than simple antioxidant protection: it’s involved in synaptic plasticity, epigenetic regulation, neurotransmitter modulation, and the control of neuroinflammatory responses [10].
A 2024 mouse study specifically examined what happens to microglia when SVCT2 expression is altered following mild traumatic brain injury [13]. The researchers found that SVCT2 expression directly modified the microglial response, affecting cell morphology, gene expression, and the inflammatory cascade. More SVCT2 activity meant a more controlled, less damaging inflammatory response. Less SVCT2 activity meant the opposite. The study was in mice, but the mechanism is coherent and the implications for understanding neuroinflammation in ageing brains are significant [13].
Evidence grade: Early stage, mouse research only, but provides a mechanistically important insight.
Here’s something you rarely see: a vitamin C story that’s honest about its own limitations.
Despite compelling evidence that vitamin C levels are depleted in the brains of Alzheimer’s patients, and despite the biological logic of antioxidant protection, dietary supplementation with vitamin C has consistently failed to produce benefits in Alzheimer’s clinical trials [1, 8]. For years, this was unexplained.
A landmark 2025 paper published in *Redox Biology* may have cracked the paradox [1]. The researchers identified a specific bottleneck: in Alzheimer’s disease, the SVCT2 transporter in microglia is progressively downregulated. In other words, the brain’s ability to actively import vitamin C from the bloodstream into microglia breaks down as the disease progresses. It doesn’t matter how much vitamin C is in your blood, if the transporter isn’t working, it can’t get into the cells that need it.
The researchers tested this in 5xFAD mice, a transgenic model that develops Alzheimer’s-like pathology. When they overexpressed SVCT2 in microglia before disease onset, the results were striking: decreased amyloid plaque burden, stronger synaptic energy capacity, and prevention of memory deficits [1, 8]. Even more remarkably, when SVCT2 was overexpressed after disease was already established, synaptic plasticity and memory performance were rescued, despite the existing amyloid plaques not being reduced [1].
This is mouse research only, and human therapeutic applications based on SVCT2 targeting are a long way off. But the finding resolves a genuine scientific mystery: why supplementation fails isn’t because vitamin C is ineffective, it’s because the delivery system breaks down. The researchers now identify SVCT2 as a “promising therapeutic target” for Alzheimer’s disease [1, 8].
A Drosophila (fruit fly) model published in 2026 adds supporting evidence at a more basic biological level. Transgenic flies expressing human Alzheimer’s-related Aβ42 protein and fed ascorbic acid showed restored antioxidant defences, partial recovery of cholinergic function, improved locomotor performance, delayed memory impairment, and extended lifespan compared to untreated AD flies [5]. Again, this is animal research. But the consistency of direction across multiple model systems is noteworthy.
Evidence grade: Promising, human and animal studies exist, but more rigorous RCTs in healthy populations are needed.
The brain applications of vitamin C extend beyond neurodegeneration. A 2020 review published in the *Journal of Nutritional Biochemistry* examined the role of vitamin C in stress-related disorders including depression and anxiety [14].
The review found that vitamin C deficiency is widely associated with stress-related conditions, and that several studies have shown ascorbic acid supplementation produces antidepressant effects and improves mood. The proposed mechanism is biologically grounded: vitamin C appears to modulate monoaminergic systems (dopamine, serotonin, noradrenaline) and glutamatergic neurotransmission, precisely the neurotransmitter systems most implicated in mood regulation and stress responses [14].
The review also notes that ascorbic acid supplementation “produces fast therapeutic response with low toxicity and high tolerance,” and suggests it as a “putative candidate” for adjuvant treatment of mood and anxiety disorders, particularly in those who are refractory to conventional treatments [14].
The evidence here is more variable than for the cognitive ageing literature, studies differ in populations, doses, and outcomes, but the direction is consistent, and the safety profile of vitamin C makes this a low-risk avenue worth taking seriously.
We want to be genuinely honest here, because the vitamin C and brain health story is compelling but genuinely unfinished in several important ways.
The clinical trial problem. As of now, dietary vitamin C supplementation in Alzheimer’s disease has failed in clinical trials [1, 8]. The 2025 SVCT2 research gives us a credible explanation for why, the transport system breaks down, but that explanation is currently based on mouse models. Human therapeutic applications targeting SVCT2 are at a very early stage.
Causation vs correlation. Most of the human cognitive data is observational. People who consume more vitamin C tend to have better cognitive scores, but we can’t rule out that both are driven by a third factor, such as a generally healthier diet, higher socioeconomic status, or more active lifestyle [4, 6, 7].
Optimal doses are unclear. The NHANES study found nonlinear dose-response effects, suggesting more is not infinitely better, but we don’t yet have solid human RCT data establishing the optimal dose for brain-specific protection [4].
Gender and age interactions need more research. The observation that women may experience a different cognitive relationship with vitamin C status than men, and that post-menopausal women may lose a previously protective advantage, is intriguing but based on small pilot studies [6, 7]. We need larger, longer-term studies.
The brain delivery problem remains unsolved. Even if you’re supplementing adequately, we don’t yet know what determines SVCT2 function in humans, how to assess it non-invasively, or how to support it through supplementation alone [1, 10].
Most of the exciting mechanistic research is in animals. The SVCT2 findings, the Drosophila research, the transgenic mouse work, all of it points in a consistent direction, but human trials confirming these mechanisms are still needed [1, 5, 12, 13].
Here’s what a sensible, informed person should actually do with this information.
Vitamin C is a water-soluble vitamin, meaning any excess your body doesn’t need is simply excreted in your urine. You cannot meaningfully overdose on it at normal supplement doses. The risk of being deficient is real, common, and, based on the research above, potentially significant for your brain as you age. The risk of supplementing daily at a normal dose is essentially negligible.
If you’re 40 or over, eat a reasonably varied diet, and assume you’re getting enough, here’s a gentle challenge: are you actually sure? Plasma vitamin C levels decline with age [6]. Smokers have substantially higher requirements [4]. People who are under chronic stress deplete their vitamin C faster [14]. Modern food processing and storage reduce vitamin C content significantly. The gap between “I eat some fruit” and “I have adequate plasma vitamin C for brain protection” may be wider than you think.
What to actually do:
1. Supplement daily, it’s the safe, practical default. Vitamin C is water-soluble, excess is excreted, and the research consistently associates adequate status with better cognitive outcomes. A dose of 500–1,000mg daily is both practical and consistent with the intake levels studied. You don’t need a blood test first.
2. If you smoke, your need is almost certainly higher. The cognitive association with vitamin C was strongest in smokers in the largest dataset reviewed [4]. This isn’t a reason to keep smoking, obviously, but it is a reason to be especially attentive to your vitamin C intake.
3. Don’t rely on vitamin C alone for brain protection. The research here is promising, not conclusive. Vitamin C appears to be one important piece of a broader picture that includes other B vitamins, vitamin D, vitamin E, and lifestyle factors [2, 3]. Think of it as part of a coherent daily strategy, not a silver bullet.
4. The SVCT2 story is worth watching. The 2025 research identifying the SVCT2 transport problem in Alzheimer’s pathology is one of the more genuinely significant mechanistic insights in recent years [1]. It doesn’t change what you should do today, but it suggests that future targeted therapies may do what simple supplementation cannot. Watch this space.
5. Mood and stress are part of the picture too. If you’re going through a difficult period, or notice that stress is affecting your mental clarity, the evidence that vitamin C supports neurotransmitter function and stress resilience, while not definitive, is consistent enough to make daily supplementation particularly worthwhile [14].
The brain is extraordinary, and it works hard every day to stay healthy. Vitamin C is not a miracle drug. But it is a remarkably safe, cheap, and biologically credible piece of the puzzle. Given what the research shows, and given the stakes, supplementing daily is simply the sensible thing to do.
[1] Enhancing microglial antioxidant capacity via the ascorbate transporter SVCT2 delays onset and modifies disease progression in mouse models of Alzheimer’s disease (2025). DOI: 10.1016/j.redox.2025.103851 | https://pubmed.ncbi.nlm.nih.gov/40907096/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12445587/
[2] The Role of Vitamins in Neurodegeneration: A Brief Review of Mechanisms, Clinical Evidence, and Therapeutic Perspectives (2025). DOI: 10.1111/psyg.70071 | https://pubmed.ncbi.nlm.nih.gov/40659185/
[3] The role of vitamins in dementia prevention and cognitive health: A comprehensive review (2025). DOI: 10.1177/13872877251379700 | https://pubmed.ncbi.nlm.nih.gov/40971320/
[4] Vitamin C intake and cognitive function in older U.S. adults: nonlinear dose-response associations and effect modification by smoking status (2025). DOI: 10.3389/fnut.2025.1585863 | https://pubmed.ncbi.nlm.nih.gov/40535041/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12173858/
[5] Effect of Ascorbic Acid on the Transgenic Drosophila Expressing Human Aβ-42 in the Neurons (2026). DOI: 10.2174/0115672050403064251130163451 | https://pubmed.ncbi.nlm.nih.gov/41503898/
[6] The Contribution of Plasma and Brain Vitamin C on Age and Gender-Related Cognitive Differences: A Mini-Review of the Literature (2020). DOI: 10.3389/fnint.2020.00047 | https://pubmed.ncbi.nlm.nih.gov/32973470/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471743/
[7] Gender Differences in Plasma Vitamin C Concentrations and Cognitive Function: A Pilot Cross-Sectional Study in Healthy Adults (2020). DOI: 10.1093/cdn/nzaa038 | https://pubmed.ncbi.nlm.nih.gov/32337476/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170048/
[8] Enhancing microglial antioxidant capacity via the ascorbate transporter SVCT2 delays onset and modifies disease progression in mouse models of Alzheimer’s disease (2025). DOI: 10.1016/j.redox.2025.103851 | https://pubmed.ncbi.nlm.nih.gov/40907096/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12445587/
[9] The Role of Vitamins in Neurodegeneration: A Brief Review of Mechanisms, Clinical Evidence, and Therapeutic Perspectives (2025). DOI: 10.1111/psyg.70071 | https://pubmed.ncbi.nlm.nih.gov/40659185/
[10] Ascorbate and its transporter SVCT2: The dynamic duo’s integrated roles in CNS neurobiology and pathophysiology (2024). https://pubmed.ncbi.nlm.nih.gov/38182073/
[11] Plasma Vitamin C Concentrations and Cognitive Function: A Cross-Sectional Study (2019). DOI: 10.3389/fnagi.2019.00072 | https://pubmed.ncbi.nlm.nih.gov/31001107/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454201/
[12] Age and Dietary Vitamin C Intake Affect Brain Physiology in Genetically Modified Mice Expressing Human Lipoprotein(A) and Unable to Synthesize Vitamin C (2021). DOI: 10.2174/1874609814666210706170326 | https://pubmed.ncbi.nlm.nih.gov/34229598/
[13] Modulation of microglia activation by the ascorbic acid transporter SVCT2 (2024). https://pubmed.ncbi.nlm.nih.gov/38972487/
[14] The role of vitamin C in stress-related disorders (2020). DOI: 10.1016/j.jnutbio.2020.108459 | https://pubmed.ncbi.nlm.nih.gov/32745879/
[15] The role of vitamins in dementia prevention and cognitive health: A comprehensive review (2025). DOI: 10.1177/13872877251379700 | https://pubmed.ncbi.nlm.nih.gov/40971320/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read Ashwagandha, an herb used in traditional medicine for over 3,000 years, shows measurable effects on memory and thinking
Quick Read EPA and DHA are two different omega-3 fatty acids found in fish oil, and they work differently in
